Evidence map›Paper›PMID 41383526›Full record

ReviewNeuroprotection (Chichester, England)2025

Stroke and associated comorbidities in Southeast Asian countries.

Aishika Datta, Soumya Akundi, Kaveri Wagh, Gangadhar Bhurle, Deepaneeta Sarmah, Arvind Sharma, Sudhir Shah, Anupom Borah, Shailendra Saraf, Pallab Bhattacharya

Abstract readReview
In one paragraph

Review in Neuroprotection (Chichester, England), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Stroke and associated comorbidities in Southeast Asian countries.Neuroprotection (Chichester, England) · 2025
    Review
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Aishika DattaDepartment of Pharmacology and Toxicology National Institute of Pharmaceutical Education and Research (NIPER), Ahmedabad Gandhinagar Gujarat India.
Soumya AkundiDepartment of Pharmacology and Toxicology National Institute of Pharmaceutical Education and Research (NIPER), Ahmedabad Gandhinagar Gujarat India.
Kaveri WaghDepartment of Pharmacology and Toxicology National Institute of Pharmaceutical Education and Research (NIPER), Ahmedabad Gandhinagar Gujarat India.
Gangadhar BhurleDepartment of Pharmacology and Toxicology National Institute of Pharmaceutical Education and Research (NIPER), Ahmedabad Gandhinagar Gujarat India.
Deepaneeta SarmahDepartment of Pharmacology and Toxicology National Institute of Pharmaceutical Education and Research (NIPER), Ahmedabad Gandhinagar Gujarat India.
Arvind SharmaDepartment of Neurology Zydus Hospital Ahmedabad Gujarat India.
Sudhir ShahDepartment of Neurology SVPIMSR and NHL Municipal Medical College & Sterling Hospital Ahmedabad Gujarat India.
Anupom BorahCellular and Molecular Neurobiology Laboratory, Department of Life Science and Bioinformatics Assam University Silchar Assam India.
Shailendra SarafDepartment of Pharmacology and Toxicology National Institute of Pharmaceutical Education and Research (NIPER), Ahmedabad Gandhinagar Gujarat India.
Pallab BhattacharyaDepartment of Pharmacology and Toxicology National Institute of Pharmaceutical Education and Research (NIPER), Ahmedabad Gandhinagar Gujarat India.ORCID 0000-0003-2867-1650

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Stroke, a leading cause of mortality and morbidity worldwide, is a complex cerebrovascular disease. Stroke risk factors are diverse, encompassing age, sex, and ethnicity. Comorbid conditions, including hypertension, hyperglycemia, hyperlipidemia, and atrial fibrillation, exacerbate stroke outcomes, contributing to the overall stroke burden within populations. In addition to these factors, lifestyle-related diseases can impact individuals across all age groups, and often include as comorbidities linked to stroke. Socioeconomic conditions, healthcare access, and the quality of clinical data significantly influence the prevalence of comorbidities. Asia, the largest continent and home to 60% of the world's population, includes many developing nations undergoing diverse economic transitions. In Southeast Asian countries, stroke prevalence is high, imposing a substantial burden on healthcare systems and economies. Research disparities in stroke are often attributed to insufficient demographic data on comorbidities. Hence, the review discusses all previously published results of hospital-based studies and data from national registries. It has been noticed that due to insufficient documentation on stroke-related comorbidities in various developing countries of Southeast Asia, stroke management becomes difficult. Therefore, this review aims to discuss the association between various comorbidities and stroke, with special emphasis on the incidence and prevalence of stroke burden in Southeast Asian countries.

Indexed as

comorbiditieshemorrhageincidenceischemiaprevalencestroke

Identifiers

PMID41383526
PMCPMC12486952

What Socratic holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.